Merck KGaA’s life science unit is still feeling the Covid demand decline
A single Covid project that’s not been renewed made an earnings dent in Merck KGaA’s manufacturing arm in the third quarter, but the company is …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
